TARDBP and frontotemporal dementia: Therefore, therapies boosting levels of importin-α and β could ameliorate both DPR and TDP-43 pathologies and prevent other pathogenic interactions, which may be beneficial for the wide range of cellular abnormalities observed in C9orf72-ALS/FTD (Figure 3, panel 6).